Physical Health of Residents in Psychiatric Institutions
This trial is active, not recruiting.
|Treatment||active awareness/lifestyle counseling|
|Sponsor||Aarhus University Hospital|
|Start date||February 2009|
|End date||August 2009|
|Trial size||350 participants|
|Trial identifier||NCT00969384, 3,3 270809|
Aim of the study: To investigate if the intervention described in this protocol has an effect on patients' and staff's physical health.
Null hypothesis: There is no difference in waist circumference, body weight, quality of life and the rate of polypharmacy between the intervention and control groups after six months.
|Endpoint classification||efficacy study|
|Intervention model||single group assignment|
time frame: 9 months
Male or female participants at least 18 years old.
Inclusion Criteria: - Living in one of the 6 institutions in Region Nordjylland Exclusion Criteria: - Not capable of speaking Danish
|Official title||Physical Health of Residents in Psychiatric Institutions|
|Principal investigator||Peter Mr Hjorth, MPH|
|Description||Background: The prevalence of physical health problems among patients suffering from psychiatric illnesses is above that seen in the average population (1). Cardiovascular diseases (2) and metabolic disorders (3;4) are common in persons diagnosed with schizophrenia (5;6). A fact that has been known for many years (7), and there has been no decrease in the prevalence of physical illness in connection with the decentralization of the psychiatric treatment which has taken place in the Western world during the last 30-40 years (8). Meta-analyses describe increased physical morbidity among patients with psychiatric diseases and increased mortality on account of somatic diseases (7). One of the reasons for the increased mortality could be the use of second generation antipsychotics that in some cases cause weight gain and metabolic syndrome which is associated with a two to threefold increase in cardiovascular mortality and a twofold increase in all-cause mortality (3;9). These effects would be expected to contribute to even higher mortality in the following years (10). The use of more than one antipsychotic drug, polypharmacy, might also play a role (11;12). Psychiatric societies, national and international health authorities advise against the use of polypharmacy (13). The quality of the general health care in patients with severe mental illness and the consensus about the prevention of somatic illness in this group of vulnerable patients need to be improved and there is evidence signifying the importance of the situation (14;15). We need more knowledge about how to integrate the prevention and care of somatic illness to this group of patients with severe psychiatric illness. This study investigates ways to improve the physical health of people with a psychiatric diagnosis.|
Call for more information